Orally Active Antiviral Tripeptide Glycyl-Prolyl-Glycinamide Is Activated by CD26 (Dipeptidyl Peptidase IV) before Transport across the Intestinal Epithelium

The tripeptide amide glycyl-prolyl-glycinamide (GPG-amide) is a new antiretroviral drug candidate, but its absorption mechanism is unknown. In this investigation, the transport and metabolism of GPG-amide were studied in a model of the human intestinal epithelium, Caco-2 cell monolayers. The results...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hubatsch, Ina, Lazorova, Lucia, Vahlne, Anders, Artursson, Per
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2005
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC549227/
https://ncbi.nlm.nih.gov/pubmed/15728907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.3.1087-1092.2005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares